When Tissue Binding and Lysosomal Trapping Break Simple Kp Estimates

Why a Phase-Based Kp Prediction Can Be Too Small

Composition-based Kp methods predict tissue-to-plasma partitioning from properties such as tissue water, lipids, and drug ionization. Their predictions are useful when the included phases capture the important reversible distribution processes. But observed tissue concentrations can also reflect strong tissue binding or accumulation in acidic intracellular organelles. These processes can increase total tissue drug relative to plasma beyond a simple phase-based estimate, particularly for lipophilic weak bases.

A high measured Kp is not, by itself, proof of either mechanism. It may also reflect differences in experimental conditions, disequilibrium, or how concentrations were measured. The useful question is whether the excess total tissue concentration is consistent with additional binding or acidic-organelle accumulation, and what evidence would help distinguish those explanations.

How Strong Tissue Binding Raises Total Kp

At equilibrium, define \(K_{u,p}\) as the ratio of unbound tissue concentration to unbound plasma concentration. Let \(f_{u,p}\) and \(f_{u,t}\) denote the unbound fractions in plasma and tissue, respectively. When these quantities refer to compatible concentrations and the same conditions, total and unbound concentrations are related by \(C_{u,p}=f_{u,p}C_p\) and \(C_{u,t}=f_{u,t}C_t\). Therefore:

This identity shows why binding matters. If unbound tissue concentration relative to unbound plasma is unchanged, but tissue binding lowers \(f_{u,t}\), total tissue concentration and \(K_p\) increase. Binding does not create a higher unbound concentration by definition; it increases the amount of total drug associated with the tissue at a given unbound concentration. A phase-based method may already represent some nonspecific binding to lipids or other included components. The concern is additional binding capacity or affinity beyond what its assumptions capture.

The simple relationship has practical limits. Tissue homogenate measurements, estimates of \(f_{u,t}\), and the assumed unbound concentration may not represent the same microscopic compartments. A computed “effective” \(f_{u,t}\) is therefore a diagnostic summary, not necessarily the unbound fraction of one homogeneous tissue phase.

Why Acidic Organelles Can Trap Weak Bases

A weak base can exist in neutral and protonated forms. In an idealized model, the neutral form crosses an organelle membrane readily, and its unbound concentration is equal on both sides at equilibrium. The protonated form crosses poorly. Because an acidic organelle has a higher proton concentration, more weak base becomes protonated there; total drug concentration can consequently be much higher inside the organelle than in the surrounding cytosol.

For a base \(B\), the equilibrium between neutral \(B\) and protonated \(BH^+\) is described by \(BH^+ \rightleftharpoons B + H^+\). The Henderson–Hasselbalch relationship gives the total-to-neutral concentration ratio \(1+10^{(pK_a-pH)}\). If neutral concentrations are equal between cytosol and lysosome, the idealized total concentration ratio is:

Here \(C_{\mathrm{lys}}\) and \(C_{\mathrm{cyt}}\) are total unbound aqueous drug concentrations in lysosome and cytosol, respectively. The expression assumes equilibrium, equal neutral concentrations, a single relevant ionization step, and no membrane-potential contribution or binding within either compartment. It describes a pH-partitioning effect, not a complete tissue Kp model.

A small organelle volume can still matter when its concentration is high. If the tissue is approximated as a mixture of cytosol and lysosome, with lysosomal volume fraction \(\phi_{\mathrm{lys}}\), the volume-weighted aqueous concentration relative to cytosol is:

Diagnosing an Elevated Observed Kp

A useful diagnosis separates the observation from its proposed explanation. First, compare the measured \(K_p\) with the phase-based estimate under matched conditions. Then ask whether total-versus-unbound concentration relationships suggest extra tissue retention, and whether the drug and tissue conditions make lysosomal trapping plausible. For a lipophilic weak base, both mechanisms may operate together: lipophilicity can support membrane access and tissue association, while protonation in acidic organelles can add intracellular retention.

Assumptions, Alternatives, and Failure Modes

The phase-based prediction is the appropriate starting point when its represented phases and equilibrium assumptions are plausible. An explicit binding or lysosomal term is a more mechanistic alternative when there is independent reason to represent that process. An empirical correction can be useful for describing a systematic discrepancy within a defined application, but it is less explanatory and may not transfer to other tissues, species, or conditions.

Several assumptions can fail. Trapping may not reach equilibrium at the sampling time; lysosomal pH and volume may differ across tissues or conditions; membrane permeability may limit access; and binding may be concentration-dependent. Homogenization can also disrupt organelles and alter pH gradients, so total homogenate concentrations do not directly reveal intact-cell subcellular distribution. Finally, a measured Kp above prediction may reflect an under-specified baseline prediction rather than one identifiable extra mechanism.

A common mistake is to see a high \(K_p\) for a lipophilic weak base and conclude that lysosomal trapping must be responsible. The correction is that this pattern is compatible with trapping, but not diagnostic: strong tissue binding, mismatched equilibrium conditions, or measurement limitations can also raise or distort observed Kp. Treat a proposed mechanism as a hypothesis to test, not as a conclusion implied by the ratio alone.